Of all the creatures found in Halloween lore, none are more mysterious than the fabled werewolf. Only emerging on a full moon night, their howl can send shivers down your spine and get you racing to ...
Matthew Galea is a features writer for CBR. He spends his day as a high school English teacher, and every other minute watching, thinking and writing about movies and television. From Lon Chaney Jr.'s ...
The latest update is out from Werewolf Therapeutics ( (HOWL)). On December 18, 2025, Werewolf Therapeutics reported a pipeline update and 2026 business priorities centered on its INDUKINE and INDUCER ...
All right, you pretty-boy vampires. Make way for a real monster man. After way too many blue moons,The Wolfmanclaws its way into theaters Friday. An update of the 1941 Universal classic The Wolf Man, ...
Zacks Investment Research on MSN
Werewolf Therapeutics (HOWL) upgraded to buy: Here's what you should know
Werewolf Therapeutics, Inc. (HOWL) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, ...
HOWL reported interim data in November from its phase 1/1b trial of WTX-124 in solid tumors. There are signs of antitumor activity at the 12 mg dose of WTX-124, with two unconfirmed partial responses ...
Werewolf Captain America is returning for a new Marvel Comics limited series, Capwolf & The Howling Commandos. Announced exclusively by AIPT Comics, Capwolf & The Howling Commandos is a four-issue ...
Werewolf Therapeutics, Inc. HOWL announced that it has entered into a collaboration and supply agreement with pharma giant Merck MRK to evaluate its lead pipeline candidate, WTX-124, in combination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback